{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:16:45Z","timestamp":1789204605159,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003092","name":"Diabetes Fonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003092","id-type":"DOI","asserted-by":"publisher"}]},{"name":"L-Nutra"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"DOI":"10.1186\/s12875-025-03027-1","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T11:49:55Z","timestamp":1762775395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cost-effectiveness of a periodic fasting-mimicking diet programme in patients with type 2 diabetes: a trial-based analysis and a lifetime model-based analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Elske L.","family":"van den Burg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra G.","family":"van Peet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein P.","family":"Schoonakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayla C.","family":"Esmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildo J.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattijs E.","family":"Numans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Pijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elske","family":"van den Akker \u2013 van Marle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"3027_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"3027_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hec.2930","volume":"23","author":"M Alva","year":"2014","unstructured":"Alva M, Gray A, Mihaylova B, Clarke P. The effect of diabetes complications on health-related quality of life: the importance of longitudinal data to address patient heterogeneity. Health Econ. 2014;23(4):487\u2013500.","journal-title":"Health Econ"},{"issue":"1","key":"3027_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12955-018-0906-y","volume":"16","author":"JN Zurita-Cruz","year":"2018","unstructured":"Zurita-Cruz JN, Manuel-Apolinar L, Arellano-Flores ML, Gutierrez-Gonzalez A, Najera-Ahumada AG, Cisneros-Gonz\u00e1lez N. Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: a cross-sectional study. Health Qual Life Outcomes. 2018;16(1):94.","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"3027_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2337\/dc17-1962","volume":"41","author":"C Bommer","year":"2018","unstructured":"Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, B\u00e4rnighausen T, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care. 2018;41(5):963\u201370.","journal-title":"Diabetes Care"},{"issue":"7","key":"3027_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jval.2017.12.019","volume":"21","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Economic burden of cardiovascular disease in type 2 diabetes: a systematic review. Value Health. 2018;21(7):881\u201390.","journal-title":"Value Health"},{"issue":"5","key":"3027_CR6","first-page":"421","volume":"19","author":"R Li","year":"2013","unstructured":"Li R, Bilik D, Brown MB, Zhang P, Ettner SL, Ackermann RT, et al. Medical costs associated with type 2 diabetes complications and comorbidities. Am J Manag Care. 2013;19(5):421\u201330.","journal-title":"Am J Manag Care"},{"issue":"4","key":"3027_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/dme.12647","volume":"32","author":"ML Alva","year":"2015","unstructured":"Alva ML, Gray A, Mihaylova B, Leal J, Holman RR. The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84). Diabet Med. 2015;32(4):459\u201366.","journal-title":"Diabet Med"},{"key":"3027_CR8","doi-asserted-by":"crossref","unstructured":"Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2014;2(10):801\u20139.","DOI":"10.1016\/S2213-8587(14)70156-1"},{"issue":"1","key":"3027_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.52239","volume":"6","author":"G Liu","year":"2023","unstructured":"Liu G, Li Y, Pan A, Hu Y, Chen S, Qian F, et al. Adherence to a healthy lifestyle in association with microvascular complications among adults with type 2 diabetes. JAMA Netw Open. 2023;6(1):e2252239.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"3027_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00125-009-1622-2","volume":"53","author":"H Sone","year":"2010","unstructured":"Sone H, Tanaka S, Iimuro S, Tanaka S, Oida K, Yamasaki Y, et al. Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia. 2010;53(3):419\u201328.","journal-title":"Diabetologia"},{"issue":"6","key":"3027_CR11","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.2337\/dc13-1928","volume":"37","author":"RR Rubin","year":"2014","unstructured":"Rubin RR, Wadden TA, Bahnson JL, Blackburn GL, Brancati FL, Bray GA, et al. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD trial. Diabetes Care. 2014;37(6):1544\u201353.","journal-title":"Diabetes Care"},{"issue":"9933","key":"3027_CR12","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/S0140-6736(14)60613-9","volume":"383","author":"SH Ley","year":"2014","unstructured":"Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet. 2014;383(9933):1999\u20132007.","journal-title":"Lancet"},{"issue":"3","key":"3027_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3945\/ajcn.112.042457","volume":"97","author":"O Ajala","year":"2013","unstructured":"Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. 2013;97(3):505\u201316.","journal-title":"Am J Clin Nutr"},{"key":"3027_CR14","doi-asserted-by":"crossref","unstructured":"van den Burg EL, Schoonakker MP, van Peet PG, van den Akker-van Marle ME, Willems van Dijk K, Longo VD, et al. Fasting in diabetes treatment (FIT) trial: study protocol for a randomised, controlled, assessor-blinded intervention trial on the effects of intermittent use of a fasting-mimicking diet in patients with type 2 diabetes. BMC Endocr Disord. 2020;20(1):94.","DOI":"10.1186\/s12902-020-00576-7"},{"key":"3027_CR15","doi-asserted-by":"crossref","unstructured":"van den Burg EL, Schoonakker MP, van Peet PG, van den Akker-van Marle EM, Lamb HJ, Longo VD, et al. Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial. Diabetologia. 2024;67(7):1245\u201359.","DOI":"10.1007\/s00125-024-06137-0"},{"key":"3027_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai8700","author":"M Wei","year":"2017","unstructured":"Wei M, Brandhorst S, Shelehchi M, Mirzaei H, Cheng CW, Budniak J, et al. Fasting-mimicking diet and markers\/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aai8700.","journal-title":"Sci Transl Med"},{"issue":"Suppl_4","key":"3027_CR17","doi-asserted-by":"publisher","first-page":"S340","DOI":"10.1093\/advances\/nmz079","volume":"10","author":"S Brandhorst","year":"2019","unstructured":"Brandhorst S, Longo VD. Protein quantity and source, fasting-mimicking diets, and longevity. Adv Nutr. 2019;10(Suppl_4):S340\u201350.","journal-title":"Adv Nutr"},{"issue":"9","key":"3027_CR18","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00125-013-2940-y","volume":"56","author":"AJ Hayes","year":"2013","unstructured":"Hayes AJ, Leal J, Gray AM, Holman RR, Clarke PM. UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom prospective diabetes study: UKPDS 82. Diabetologia. 2013;56(9):1925\u201333.","journal-title":"Diabetologia"},{"issue":"10","key":"3027_CR19","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"4","key":"3027_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","volume":"19","author":"MM Versteegh","year":"2016","unstructured":"Versteegh MM, Vermeulen KM, Evers SMAA, de Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19(4):343\u201352.","journal-title":"Value Health"},{"key":"3027_CR21","unstructured":"Hakkaart-van Roijen L, van der Linden N, Bouwmans C, Kanters T, Tan SS. Costing manual: methodology of costing research and reference prices for economic evaluations in healthcare [in Dutch: Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg]. Erasmus Universiteit Rotterdam. 2015:p. 2\u201365."},{"key":"3027_CR22","unstructured":"Central Bureau of Statistics [in Dutch: Centraal Bureau voor de Statistiek]. Consumentenprijzen; prijsindex 2015=100. Available from: https:\/\/www.cbs.nl\/nl-nl\/cijfers\/detail\/83131ned. Cited 26\u201310\u20132023."},{"key":"3027_CR23","doi-asserted-by":"crossref","unstructured":"Rubin DB. Multiple Imputatino for Nonresponse in Surveys.1987.","DOI":"10.1002\/9780470316696"},{"key":"3027_CR24","doi-asserted-by":"crossref","unstructured":"Mutubuki EN, El Alili M, Bosmans JE, Oosterhuis T, F JS, Ostelo R, et al. The statistical approach in trial-based economic evaluations matters: get your statistics together! BMC Health Serv Res. 2021;21(1):475.","DOI":"10.1186\/s12913-021-06513-1"},{"key":"3027_CR25","unstructured":"National Institute of Budget Education [in Dutch: Nationaal Instituut voor Budgetvoorlichting (nibud)]. Huishoudelijke uitgaven. Available from: https:\/\/www.nibud.nl\/consumenten\/wat-geeft-u-uit-aan-voeding\/. Cited 28\u201311\u20132022."},{"issue":"11","key":"3027_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187477","volume":"12","author":"TA Kanters","year":"2017","unstructured":"Kanters TA, Bouwmans CAM, van der Linden N, Tan SS, Hakkaart-van RL. Update of the Dutch manual for costing studies in health care. PLoS One. 2017;12(11):e0187477.","journal-title":"PLoS One"},{"issue":"15","key":"3027_CR27","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577\u201389.","journal-title":"N Engl J Med"},{"issue":"10","key":"3027_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14656","volume":"38","author":"J Leal","year":"2021","unstructured":"Leal J, Alva M, Gregory V, Hayes A, Mihaylova B, Gray AM, et al. Estimating risk factor progression equations for the UKPDS outcomes model 2 (UKPDS 90). Diabet Med. 2021;38(10):e14656.","journal-title":"Diabet Med"},{"issue":"10","key":"3027_CR29","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.jval.2020.05.018","volume":"23","author":"HA Dakin","year":"2020","unstructured":"Dakin HA, Farmer A, Gray AM, Holman RR. Economic evaluation of factorial trials: cost-utility analysis of the Atorvastatin in factorial with Omega EE90 risk reduction in Diabetes 2 \u00d7 2 \u00d7 2 factorial trial of Atorvastatin, Omega-3 fish oil, and action planning. Value Health. 2020;23(10):1340\u20138.","journal-title":"Value Health"},{"key":"3027_CR30","unstructured":"Zwaap J, Knies S, Meijden Cvd, Staal P, Heiden Lvd. Cost-effectiveness in practice [in Dutch: Kosteneffectiviteit in de praktijk]. National Health Care Institute [in Dutch: Zorginstituut Nederland]. 2015."},{"issue":"8","key":"3027_CR31","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1210\/clinem\/dgac197","volume":"107","author":"A Sulaj","year":"2022","unstructured":"Sulaj A, Kopf S, von Rauchhaupt E, Kliemank E, Brune M, Kender Z, et al. Six-month periodic fasting in patients with type 2 diabetes and diabetic nephropathy: a proof-of-concept study. J Clin Endocrinol Metab. 2022;107(8):2167\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"3027_CR32","doi-asserted-by":"publisher","first-page":"6615295","DOI":"10.1155\/2020\/6615295","volume":"2020","author":"F Tang","year":"2020","unstructured":"Tang F, Lin X. Effects of Fasting-Mimicking Diet and Specific Meal Replacement Foods on Blood Glucose Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial. Oxid Med Cell Longev. 2020;2020:6615295.","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"3027_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/heapro\/dam027","volume":"22","author":"K Dalziel","year":"2007","unstructured":"Dalziel K, Segal L. Time to give nutrition interventions a higher profile: cost-effectiveness of 10 nutrition interventions. Health Promot Int. 2007;22(4):271\u201383.","journal-title":"Health Promot Int"},{"issue":"4","key":"3027_CR34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0002-8223(99)00105-4","volume":"99","author":"JF Sheils","year":"1999","unstructured":"Sheils JF, Rubin R, Stapleton DC. The estimated costs and savings of medical nutrition therapy: the Medicare population. J Am Diet Assoc. 1999;99(4):428\u201335.","journal-title":"J Am Diet Assoc"},{"issue":"9","key":"3027_CR35","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/S0002-8223(95)00277-4","volume":"95","author":"MJ Franz","year":"1995","unstructured":"Franz MJ, Splett PL, Monk A, Barry B, McClain K, Weaver T, et al. Cost-effectiveness of medical nutrition therapy provided by dietitians for persons with non-insulin-dependent diabetes mellitus. J Am Diet Assoc. 1995;95(9):1018\u201324.","journal-title":"J Am Diet Assoc"},{"issue":"10","key":"3027_CR36","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1007\/s00125-020-05224-2","volume":"63","author":"Y Xin","year":"2020","unstructured":"Xin Y, Davies A, Briggs A, McCombie L, Messow CM, Grieve E, et al. Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)\/counterweight-plus weight management programme. Diabetologia. 2020;63(10):2112\u201322.","journal-title":"Diabetologia"},{"issue":"9","key":"3027_CR37","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1080\/13696998.2018.1468334","volume":"21","author":"M Nuijten","year":"2018","unstructured":"Nuijten M, Marczewska A, Araujo Torres K, Rasouli B, Perugini M. A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States. J Med Econ. 2018;21(9):835\u201344.","journal-title":"J Med Econ"},{"issue":"1","key":"3027_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dc13-2112","volume":"37","author":"DM Nathan","year":"2014","unstructured":"Nathan DM. The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9\u201316.","journal-title":"Diabetes Care"},{"issue":"2","key":"3027_CR39","doi-asserted-by":"publisher","first-page":"C570","DOI":"10.1152\/ajpcell.00201.2022","volume":"323","author":"Z Chen","year":"2022","unstructured":"Chen Z, Natarajan R. Epigenetic modifications in metabolic memory: what are the memories, and can we erase them? Am J Physiol Cell Physiol. 2022;323(2):C570\u201382.","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-03027-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-025-03027-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-03027-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:05:46Z","timestamp":1762884346000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-025-03027-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3027"],"URL":"https:\/\/doi.org\/10.1186\/s12875-025-03027-1","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Fasting In diabetes Treatment (FIT) trial protocol and amendments were approved by the Medical Research Ethics Committee of the LUMC (identifiers NL63892.058.18 and P18.049). All study participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HJL has received consulting fees from Royal Philips and was member of the board of trustees of the Society for Cardiovascular Magnetic Resonance and European Union of Medical Specialists Radiology section without payment. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"351"}}